“My team at True You Weight Loss team has been utilizing the Spatz3 gastric weight loss balloon since 2021, beginning with our participation in the FDA post-approval study. Our experience has allowed us to observe the balloon’s unique feature: post-implantation adjustability. This capability provides a significant benefit, enabling downsizing in the event of the dreaded but sometimes unavoidable situation: balloon intolerance. The ability to downsize provides a balloon-salvaging option but also additional confidence to patients as they begin their weight loss journey. As a bonus, the upsizing potential can boost weight loss for those patients who need greater levels of satiation. The Spatz3 balloon represents an important option in our endoscopic bariatric toolkit.”
Dr. Christopher McGowan, MD, ABOM, MSCR, AGAF, FASGE – USA
World-renowned leader in Endobariatrics & Founder / CEO of True You Weight Loss

